Golden Gate Private Equity adds The Advisory Board Company (ABCO) to its portfolio

The Advisory Board Company (ABCO) : Golden Gate Private Equity added new position in The Advisory Board Company during the most recent quarter end. The investment management firm now holds 83,900 shares of The Advisory Board Company which is valued at $3,481,011 , the company said in a statement filed on Aug 15, 2016 with the SEC.The Advisory Board Company makes up approximately 1.67% of Golden Gate Private Equity’s portfolio.

Other Hedge Funds, Including , Brown Brothers Harriman Co added ABCO to its portfolio by purchasing 107 company shares during the most recent quarter which is valued at $4,439.Blackrock Institutional Trust Company N.a. boosted its stake in ABCO in the latest quarter, The investment management firm added 15,188 additional shares and now holds a total of 1,045,552 shares of The Advisory Board Company which is valued at $43,379,952. The Advisory Board Company makes up approx 0.01% of Blackrock Institutional Trust Company N.a.’s portfolio.Msi Financial Services Inc reduced its stake in ABCO by selling 51 shares or 31.68% in the most recent quarter. The Hedge Fund company now holds 110 shares of ABCO which is valued at $4,081.

The Advisory Board Company opened for trading at $42.2 and hit $42.45 on the upside on Thursday, eventually ending the session at $42.18, with a gain of 0.07% or 0.03 points. The heightened volatility saw the trading volume jump to 2,20,320 shares. Company has a market cap of $1,698 M.

On the company’s financial health, The Advisory Board Company reported $0.47 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.34. The company had revenue of $198.40 million for the quarter, compared to analysts expectations of $196.49 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.

Many Wall Street Analysts have commented on The Advisory Board Company. The Advisory Board Company was Upgraded by Craig Hallum to ” Buy” on Jul 28, 2016. Company shares were Reiterated by FBR Capital on Jul 28, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 37 from a previous price target of $35 .The Advisory Board Company was Downgraded by Raymond James to ” Mkt Perform” on Jul 19, 2016.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Leave a Reply

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.